Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - CASH & EQUIVALENTS
Cash & Equivalents SGMO - Sangamo Therapeutics, Inc.
45.2 M
LAST VALUE
-49.73%
2 YEAR CAGR
-20.28%
5 YEAR CAGR
16.07%
10 YEAR CAGR